Markets
Borrow
Earn
Invest
Private
Security
Newsroom
More
Log In
Sign Up
Markets
Market Overview
Indices and commodities.
Digital Credit
Bitcoin treasury preferreds.
AI Stocks
The artificial intelligence theme.
Bitcoin Treasuries
Companies holding bitcoin.
Economy
Sectors, global markets and rates.
Popular Portfolios
13F filings, smart money.
Borrow
Borrow
Borrow USDT or USDC against your BTC without giving it up.
ReFi
Switch your bitcoin-backed loan and pay less interest.
Earn
Carry Trade
Borrow, invest, keep the spread.
Stock Dividends
Dividends from tokenized equities.
Invest
Private
Security
Newsroom
More
Company
About Us
Our leadership team, mission, and investors.
Whitepaper
Vision, purpose, and architecture behind Roxom.
Legal
Terms, privacy, and disclosures.
Resources
Help Center
Guides, FAQs & support.
Rulebook
Trading logic, platform rules, and fundamentals.
API Docs
Connect, authenticate, and build with our API.
Status
Current platform health and incidents.
Chart
Financials
Earnings
News
About
Dividends
Insider
Filings
BTC
SATS
USD
1d
1w
1m
6m
YTD
1y
5y
All
Loading chart
1 BTC
=
- USD
BTC
SATS
Loading market data...
Chart
Financials
Earnings
News
About
Dividends
Insider
Filings
BTC
SATS
USD
1d
1w
1m
6m
YTD
1y
5y
All
Loading chart
VK
Viking Therapeutics, Inc
VKTX
Mkt Cap
$3.20B
Volume
7.15M
Next Earnings
October 28th
Chart
Financials
Earnings
News
About
Dividends
Insider
Filings
BTC
SATS
USD
1d
1w
1m
6m
YTD
1y
5y
All
Loading chart
VK
VKTX
VK
Viking Therapeutics, Inc
VKTX
News
·
Viking Therapeutics, Inc. (VKTX) Falls More Steeply Than Broader Market: What Investors Need to Know
Mkt Cap
$3.48B
Volume
7.15M
Next Earnings
October 28th
Chart
Financials
Earnings
News
About
Insider
Filings
Highlights
Income Statement
Balance Sheet
Cash Flow
Revenue
$0
Net Income
-$359.64M
-227.1% YoY
EBITDA
-$393.34M
-160.6% YoY
Free Cash Flow
-$278.69M
-217.4% YoY
Cash & Equivalents
$165.81M
Gross Margin
N/A
Net Margin
N/A
EPS
$-3.19
P/E Ratio
-7.89x
Forward P/E
N/A
Profitability
-$200.00M
-$150.00M
-$100.00M
-$50.00M
$0.00
Q2 '25
Q3 '25
Q4 '25
Q1 '26
Q2 '26
Revenue
Net Income
Earnings Per Share
-$1.50
-$1.00
-$0.50
$0.00
$0.50
Q2 '25
Q3 '25
Q4 '25
Q1 '26
Q2 '26
Actual
Holdings
Open Orders (0)
Positions (0)
Order History
Dividends
Transfers
Log In
to start trading
VK
VKTX
Viking Therapeutics, Inc
Buy
Sell
Market
Limit
Soon
VKTX
25%
50%
75%
Max
Pay with
—
Start Trading
Available Balance
0.00
Your Position
You don't own any VKTX yet.
Related Tickers
LL
LLY
—
MD
MDGL
—
PF
PFE
—
Earnings